Contract Manufacturing at an Inflection Point — AI Infrastructure Demand Meets a Re-Rating Story

Sanmina Corporation is a global provider of integrated manufacturing solutions, components, and after-market services. The company operates primarily as an electronics manufacturing services (EMS) provider, producing complex electronic and mechanical systems for original equipment manufacturers across end markets including communications networks, cloud and data infrastructure, industrial, medical, defense and aerospace, and automotive.

How it makes money: Sanmina generates revenue through manufacturing service agreements with OEM customers. The model is fundamentally a conversion business — customers supply demand and often much of the design, while Sanmina supplies the footprint, the process engineering, the supply-chain orchestration, and the working capital. Revenue is recognized on shipped product, and profitability is driven by the spread between the price of the manufactured assembly and the cost of materials, labor, and overhead. Because materials typically represent the majority of cost of goods sold, gross margins are structurally thin, and the company's profitability depends on program mix, utilization, and operational execution rather than pricing power in the conventional sense.

Customers: Sanmina's customer base is concentrated in large, technically demanding OEMs — networking and communications equipment vendors, cloud and hyperscale infrastructure operators, medical device manufacturers, and defense primes. These relationships are typically long-dated and sticky, because qualifying a new manufacturer into a complex program is expensive and slow for the customer. That stickiness is the company's most durable asset and its principal defense against low-cost competition.

Scale: With a market capitalization of $11.6B and 53.60M shares outstanding, Sanmina is a mid-cap manufacturer with a global footprint spanning North America, Europe, and Asia. Its scale is sufficient to serve multinational customers with multi-region requirements, but small enough — in share count terms — that per-share earnings are highly sensitive to operational improvement.

Near-term (next 4–8 quarters):

• AI and cloud infrastructure programs. The most visible near-term driver. Demand for power, thermal, and high-speed interconnect assemblies tied to AI compute buildouts is the primary reason the market is re-rating the stock. Expect lumpy but directionally strong contribution.
• Defense and aerospace budgets. Multi-year procurement cycles in Western defense spending provide a durable, less cyclical revenue base with favorable margin characteristics and long program lives.
• Medical device manufacturing. A steady, high-mix, high-barrier end market that rewards qualification and regulatory expertise — exactly the kind of work that supports margin expansion.

Medium-term (2–5 years):

• Mix migration toward engineering-led programs. The strategic imperative is to shift the revenue base away from commodity, price-competitive assembly toward programs where Sanmina's process engineering and supply-chain scale command a premium.
• Capacity investment in high-complexity geographies. Nearshoring and friendshoring trends favor manufacturers with Western Hemisphere and allied-nation footprints, particularly for defense and medical customers with supply-chain security requirements.
• Operating leverage on a fixed footprint. As utilization improves on existing capacity, incremental revenue should convert to profit at a rising rate — the mechanical source of EPS growth even without dramatic top-line expansion.

Note: FY2023–FY2025 figures are directional reconstructions consistent with the disclosed EPS of $5.60 and should be treated as illustrative of trend rather than precise historicals. Forward figures are analyst projections.

The narrative behind these numbers is straightforward: revenue growth is moderate and somewhat cyclical, but the margin line is where the story lives. A move from roughly 8.5% to 10.8% gross margin over four years, on a revenue base approaching $10B, adds several hundred million dollars of gross profit — and because the operating cost structure is largely fixed, the majority of that falls to operating income. That is the mechanism by which EPS can grow from roughly $5.60 today toward a high-single-digit or low-double-digit figure by FY2027. The risk to this trajectory is program concentration: a single large AI or networking program rolling off, or a customer inventory correction, could compress utilization and reverse the margin gains quickly.

The global EMS market is large — commonly estimated in the range of $500B+ in annual revenue across all service categories — but it is highly fragmented and stratified. At the top sit a handful of scaled players with global footprints; below them is a long tail of regional and specialized manufacturers competing primarily on price.

Competitive positioning: Sanmina competes in the mid-to-high-complexity tier. It does not attempt to win on lowest-cost commodity assembly at the scale of the largest players, nor does it operate as a niche specialist. Its differentiation rests on (1) engineering and process capability for complex, high-reliability products, (2) a multi-region footprint that satisfies supply-chain security requirements, and (3) long-tenured customer relationships in regulated end markets. The strategic vulnerability is the middle: squeezed on cost by larger competitors and on specialization by focused niche players.

Named comparables:

The Celestica and Jabil comparisons are the most instructive for valuation: both have been re-rated materially by the market's willingness to pay for AI infrastructure exposure, and Sanmina's multiple expansion is best understood as the market applying a similar (if more modest) logic.

DCF discussion: A discounted cash flow approach for Sanmina is unusually sensitive to terminal margin assumptions. Because the business converts a large revenue base at a thin spread, small changes in steady-state operating margin produce enormous changes in enterprise value. Under a base case assuming mid-single-digit revenue growth, operating margin expanding toward 7%, a weighted average cost of capital in the 9–10% range (reflecting the 1.60 beta and the cyclicality of the end markets), and a terminal growth rate of 2.5%, the implied equity value sits in a range that brackets the current $216.54 price — with the upside case driven almost entirely by whether margins hold above 7%. The honest conclusion is that the DCF does not provide a tight anchor here; it provides a sensitivity map, and the stock's value is a function of a margin assumption the market is still debating.

Comparable-company multiples:

Multiples are approximate and directional, intended to frame relative positioning rather than to serve as precise marks.

On trailing EPS of $5.60, SANM trades at roughly 38.7x — a premium to Flex and Benchmark, in line with Celestica and above Jabil on a forward basis. That premium is defensible only if the margin expansion thesis delivers. If it does, the forward multiple compresses rapidly and the stock looks cheap; if it stalls, the multiple is the risk.

• Program concentration. A significant share of revenue derives from a limited number of large OEM customers. The loss, insourcing, or delay of a major program would compress utilization and reverse margin gains quickly — the single largest threat to the thesis.
• AI infrastructure cyclicality. The demand driving the current re-rating is capital-expenditure driven and inherently lumpy. Hyperscaler spending pauses, digestion periods, or a shift in architecture could create sharp revenue air-pockets with little warning.
• Margin execution risk. The entire valuation rests on continued gross margin expansion. EMS margins are operationally fragile — a single mis-executed ramp, yield problem, or pricing concession can erase several quarters of progress.
• Working capital and inventory exposure. Contract manufacturers carry inventory on behalf of customers. In a demand downturn, excess and obsolete inventory charges hit gross margin directly, and receivable collection can stretch.
• Valuation and positioning risk. At ~38.7x trailing earnings with a 1.60 beta and 5.96% of float shorted, the stock is priced for good news. The 6.51% single-day move on volume that was only ~11% of average suggests fragile liquidity — moves in either direction can be violent.